Showing results (21-30 of 24) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
ESMO Open|December 4, 2022
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesotheliomaS Canova, G L Ceresoli, F Grosso, et al.British Journal of Cancer|July 18, 2013
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesotheliomaG L Ceresoli, P A Zucali, M Mencoboni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2020
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)Y Metaxas, M Früh, E I Eboulet, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2011
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialM Bachner, Y Loriot, M Gross-Goupil, et al.Pageof 3